Skip to content

Faculty profile

Thomas Mavrakanas

Back to faculty
ResearcherMedicine/CardiologyMcGill University

This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a McGill University directory, so their courses and email address may be missing. Find their university profile.

Latest papers

  • Meta-analysis evaluating apixaban in patients with atrial fibrillation and end-stage renal disease requiring dialysis.

    Journal of arrhythmia · 2024

  • The impact of transsphenoidal surgery on pituitary function in patients with non-functioning macroadenomas.

    Endocrine · 2023

  • Bioimpedance-Guided Monitoring of Volume Status in Patients With Kidney Disease: A Systematic Review and Meta-Analysis.

    Canadian journal of kidney health and disease · 2023

All 8 publications

Latest funding

  • Impact of Canagliflozin on peritoneal membrane function and integrity in patients with kidney failure on Peritoneal Dialysis

    CIHR · 2026 · Nominated PI

    $187,424
  • Deconstructing the phenotypic heterogeneity of type-2-diabetes associated with cardiovascular outcomes through multi-omics profiling and clinical clustering: DECIDE-CCVS program

    CIHR · 2025 · Principal investigator

    $703,800
  • Strategies for the management of Atrial Fibrillation in patiEnts receiving Dialysis 2 (SAFE-D2)

    CIHR · 2025 · Co-investigator

    $1,874,251
All 8 grants and awards
Something wrong or missing on this profile? Suggest a correction